Manufacturer
141 recalls in our database name Glenmark Pharmaceuticals Inc., USA as the manufacturing or recalling firm.
Of the 141 recalls from Glenmark Pharmaceuticals Inc., USA we have scored against our rubric, 1 (1%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 14 (10%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Glenmark Pharmaceuticals is recalling Ranitidine Tablets USP 300 mg because of the presence of the NDMA impurity.
Glenmark Pharmaceuticals is recalling Ranitidine Tablets USP 300 mg because the FDA detected the NDMA impurity in the product.
Glenmark Pharmaceuticals is recalling Ranitidine Tablets USP 150 mg because testing detected the presence of the NDMA impurity.
Glenmark Pharmaceuticals is recalling Ranitidine Tablets USP 150 mg because the product contains the NDMA impurity.
Glenmark Pharmaceuticals is recalling 217,956 bottles of Ranitidine Tablets USP 150 mg nationwide because the product contains the NDMA impurity.
Glenmark Pharmaceuticals is recalling Clobetasol Propionate Foam because the product is not foaming or is coming out as liquid.
Glenmark Pharmaceuticals is recalling Clobetasol Propionate Foam because the product is not foaming or is coming out as liquid.
Glenmark Pharmaceuticals is recalling Estradiol Vaginal Inserts because the applicator plunger may be difficult to push.
Glenmark Pharmaceuticals is recalling 31,224 tubes of Clotrimazole and Betamethasone Dipropionate Cream due to complaints of a liquidy texture caused by temperature abuse.
Glenmark Pharmaceuticals is recalling Mometasone Furoate Cream 0.1% because patients reported the product felt gritty. The recall covers 15g and 45g tubes distributed nationwide.
Glenmark Pharmaceuticals is recalling Estradiol Vaginal Inserts because the plunger delivery system is not functioning properly.
Glenmark Pharmaceuticals is recalling 2,076 bottles of Pravastatin Sodium 20 mg tablets because a foreign tablet was found in the product.
Glenmark Pharmaceuticals is recalling Estradiol Vaginal Inserts because customer complaints reported a malfunctioning plunger on the applicator delivery system.
Glenmark Pharmaceuticals is recalling 5,016 blister packs of Aprepitant 40 mg capsules because some packs are missing capsules.
Glenmark Pharmaceuticals is recalling Indomethacin Capsules 50 mg because the bottles display incorrect adult dosage instructions.
Glenmark Pharmaceuticals is recalling Mometasone Furoate Cream due to market complaints about a gritty texture.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Glenmark Pharmaceuticals
Indian multinational pharmaceutical company
Source: Wikidata (Q5568612), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.